
What We’re Reading: Social Security, Medicare Warnings; FDA Experts Back OTC Naloxone; Moderna’s COVID-19 Vaccines Stay Free
Social Security and Medicare spending could double by 2023; FDA panel experts want naloxone to be available over the counter after the drug information is revised; Moderna announced its COVID-19 vaccines will stay free, and the Biden administration might keep tests and treatments free for the uninsured.
Social Security, Medicare Spending Might Double by 2033
The Congressional Budget Office (CBO) said Wednesday that spending on Medicare and Social Security is projected to double by 2033, due to the increasing cost of medical services and a growing number of eligible beneficiaries,
FDA Panel Supports OTC Naloxone
A panel of outside FDA experts unanimously voted on Wednesday that the overdose-reversing drug naloxone should be offered over the counter to help fight the national opioid crisis,
Moderna COVID-19 Vaccines to Stay Free
Moderna announced that people who are insured will be able to get a free COVID-19 vaccine from their doctor’s office or a pharmacy, and uninsured people or those whose insurance won’t cover the vaccine can get it for free through Moderna’s patient assistance program,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.